| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,434 |
7,797 |
$456K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,816 |
2,601 |
$397K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,905 |
11,306 |
$204K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
31,051 |
20,156 |
$203K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,944 |
2,632 |
$188K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
4,838 |
4,247 |
$172K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,042 |
1,003 |
$150K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
4,614 |
3,958 |
$130K |
| A0425 |
Ground mileage, per statute mile |
12,589 |
9,208 |
$111K |
| 90834 |
Psychotherapy, 45 minutes with patient |
28,043 |
9,110 |
$106K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,334 |
3,902 |
$104K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,120 |
3,719 |
$97K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
22,713 |
15,428 |
$91K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,554 |
8,337 |
$67K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,871 |
5,650 |
$63K |
| 71045 |
Radiologic examination, chest; single view |
4,357 |
3,834 |
$62K |
| 71046 |
Radiologic examination, chest; 2 views |
3,947 |
3,691 |
$60K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,769 |
4,305 |
$55K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
415 |
383 |
$45K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,748 |
7,783 |
$41K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
432 |
400 |
$40K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,328 |
10,656 |
$40K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
2,081 |
1,531 |
$39K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,164 |
2,472 |
$36K |
| 80053 |
Comprehensive metabolic panel |
28,480 |
24,231 |
$34K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,739 |
4,553 |
$33K |
| G0378 |
Hospital observation service, per hour |
478 |
278 |
$30K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,764 |
1,203 |
$28K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
908 |
877 |
$27K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,931 |
3,785 |
$26K |
| 20610 |
|
2,173 |
1,147 |
$22K |
| 72100 |
|
1,276 |
1,222 |
$22K |
| 90837 |
Psychotherapy, 53 minutes with patient |
4,098 |
1,283 |
$21K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
264 |
242 |
$21K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,915 |
1,306 |
$20K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,504 |
25,288 |
$19K |
| 90832 |
Psychotherapy, 30 minutes with patient |
4,849 |
3,055 |
$19K |
| 73564 |
|
1,224 |
1,085 |
$18K |
| 73030 |
|
1,089 |
974 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,904 |
11,318 |
$15K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,282 |
1,218 |
$15K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
444 |
393 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,860 |
1,491 |
$12K |
| 99442 |
|
1,276 |
1,209 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,187 |
3,079 |
$11K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,742 |
666 |
$10K |
| 73630 |
|
809 |
709 |
$10K |
| 99215 |
Prolong outpt/office vis |
1,335 |
870 |
$10K |
| 83735 |
|
13,011 |
10,102 |
$9K |
| 76830 |
Ultrasound, transvaginal |
510 |
503 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,714 |
8,452 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,358 |
6,026 |
$8K |
| 84484 |
|
6,223 |
4,976 |
$8K |
| 73610 |
|
684 |
623 |
$8K |
| 96376 |
|
1,451 |
1,137 |
$8K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
132 |
128 |
$7K |
| 83880 |
|
2,740 |
2,342 |
$7K |
| 76641 |
|
332 |
319 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,304 |
3,217 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
39,213 |
30,086 |
$6K |
| 71250 |
|
80 |
76 |
$6K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
106 |
103 |
$6K |
| 90791 |
Psychiatric diagnostic evaluation |
1,136 |
698 |
$6K |
| 73502 |
|
280 |
262 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
2,488 |
1,955 |
$6K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
84 |
79 |
$5K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
187 |
175 |
$5K |
| 51798 |
|
283 |
274 |
$5K |
| 87040 |
|
2,456 |
2,022 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,030 |
688 |
$4K |
| T1015 |
Clinic visit/encounter, all-inclusive |
2,766 |
2,281 |
$4K |
| 80306 |
|
4,013 |
3,462 |
$4K |
| 93971 |
|
97 |
94 |
$4K |
| 82607 |
|
3,027 |
2,931 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,856 |
3,547 |
$4K |
| 96367 |
|
452 |
343 |
$4K |
| 97162 |
|
376 |
340 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,507 |
4,893 |
$4K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
214 |
101 |
$4K |
| 93017 |
|
88 |
85 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
8,853 |
7,669 |
$3K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
493 |
485 |
$3K |
| 82728 |
|
2,645 |
2,545 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
71 |
70 |
$3K |
| 82803 |
|
2,104 |
1,730 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
533 |
283 |
$3K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
580 |
494 |
$3K |
| 71271 |
|
283 |
279 |
$3K |
| 83605 |
|
3,273 |
2,728 |
$3K |
| 99443 |
|
206 |
194 |
$2K |
| 80061 |
Lipid panel |
9,251 |
8,988 |
$2K |
| 84439 |
|
1,855 |
1,784 |
$2K |
| 87077 |
|
2,901 |
2,486 |
$2K |
| 82570 |
|
2,170 |
2,065 |
$2K |
| 82043 |
|
1,922 |
1,891 |
$2K |
| 73130 |
|
212 |
181 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,461 |
3,759 |
$2K |
| 85610 |
|
6,243 |
3,818 |
$2K |
| 85027 |
|
1,795 |
1,446 |
$2K |
| 93225 |
|
75 |
75 |
$2K |
| 82948 |
|
2,808 |
1,774 |
$1K |
| 87631 |
|
1,595 |
1,509 |
$1K |
| 81015 |
|
5,355 |
4,732 |
$1K |
| 83690 |
|
4,257 |
3,708 |
$1K |
| 83550 |
|
2,081 |
2,015 |
$1K |
| 86140 |
|
3,855 |
3,420 |
$1K |
| 87168 |
|
1,472 |
1,351 |
$1K |
| 73221 |
|
38 |
37 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,467 |
550 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,024 |
1,694 |
$1K |
| 76775 |
|
42 |
40 |
$1K |
| 83037 |
|
332 |
330 |
$1K |
| 83540 |
|
2,657 |
2,565 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
348 |
289 |
$1K |
| 97161 |
|
116 |
108 |
$1K |
| 73110 |
|
133 |
115 |
$1K |
| 81003 |
|
8,684 |
7,045 |
$1K |
| 86803 |
|
998 |
971 |
$1K |
| 85379 |
|
2,048 |
1,861 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,252 |
1,745 |
$1K |
| 99205 |
Prolong outpt/office vis |
133 |
67 |
$999.66 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
389 |
382 |
$998.91 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
172 |
129 |
$941.96 |
| 85651 |
|
2,198 |
1,985 |
$904.82 |
| 76536 |
|
51 |
51 |
$889.19 |
| 85730 |
|
1,594 |
1,347 |
$850.89 |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
1,202 |
511 |
$805.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
420 |
284 |
$801.95 |
| J3490 |
Unclassified drugs |
312 |
245 |
$793.91 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,619 |
3,595 |
$792.19 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
21 |
12 |
$692.55 |
| 82077 |
|
847 |
757 |
$640.70 |
| 97602 |
|
68 |
27 |
$609.13 |
| 82746 |
|
586 |
554 |
$571.30 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,724 |
1,458 |
$570.36 |
| 74018 |
|
53 |
51 |
$530.15 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
250 |
198 |
$523.41 |
| 85007 |
|
1,351 |
1,068 |
$486.30 |
| A0434 |
Specialty care transport (sct) |
27 |
25 |
$481.09 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
102 |
42 |
$463.69 |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
30 |
26 |
$461.70 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,171 |
972 |
$455.92 |
| 77066 |
Tomosynthesis, mammo |
24 |
24 |
$445.95 |
| 95251 |
|
267 |
259 |
$438.24 |
| 86850 |
|
260 |
215 |
$427.29 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
133 |
93 |
$397.15 |
| 77065 |
Tomosynthesis, mammo |
24 |
24 |
$383.32 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
362 |
261 |
$373.00 |
| 36600 |
|
65 |
50 |
$322.95 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,562 |
2,535 |
$317.22 |
| 51702 |
|
16 |
13 |
$308.17 |
| 87081 |
|
2,887 |
2,744 |
$302.57 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
442 |
390 |
$290.78 |
| 81025 |
|
3,411 |
3,004 |
$279.30 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
132 |
114 |
$273.84 |
| 94010 |
|
14 |
13 |
$273.56 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
119 |
108 |
$255.04 |
| 95806 |
|
14 |
13 |
$244.59 |
| 82550 |
|
464 |
391 |
$228.69 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
222 |
52 |
$214.05 |
| 94727 |
|
13 |
12 |
$213.17 |
| 87205 |
|
1,341 |
1,256 |
$212.20 |
| 80305 |
|
2,642 |
1,953 |
$209.79 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
21 |
19 |
$207.52 |
| 86900 |
|
185 |
142 |
$206.56 |
| 86901 |
|
185 |
142 |
$201.57 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
482 |
469 |
$191.30 |
| 72070 |
|
12 |
12 |
$178.80 |
| 87430 |
|
1,318 |
1,279 |
$177.81 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
741 |
718 |
$177.26 |
| 90849 |
|
317 |
190 |
$162.60 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
71 |
62 |
$157.69 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,242 |
2,142 |
$151.87 |
| 81002 |
|
1,850 |
1,539 |
$147.93 |
| 84550 |
|
192 |
178 |
$146.18 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
87 |
78 |
$137.40 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
86 |
81 |
$133.04 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
577 |
479 |
$128.17 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
51 |
50 |
$120.00 |
| 97035 |
|
95 |
27 |
$118.65 |
| 86618 |
|
109 |
99 |
$118.58 |
| 82150 |
|
552 |
507 |
$118.06 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
25 |
15 |
$113.12 |
| 80320 |
|
141 |
122 |
$100.25 |
| 97166 |
|
14 |
14 |
$93.31 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
982 |
946 |
$91.48 |
| 93016 |
|
90 |
86 |
$91.22 |
| J2060 |
Injection, lorazepam, 2 mg |
416 |
303 |
$87.58 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
134 |
132 |
$86.08 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
424 |
173 |
$79.05 |
| 93018 |
|
89 |
85 |
$76.96 |
| 77080 |
|
53 |
53 |
$76.89 |
| 83615 |
|
107 |
104 |
$74.28 |
| G0008 |
Administration of influenza virus vaccine |
31 |
30 |
$72.11 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,090 |
1,049 |
$67.45 |
| 87070 |
|
143 |
139 |
$67.21 |
| 84156 |
|
93 |
88 |
$64.00 |
| 98968 |
|
39 |
36 |
$60.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
689 |
655 |
$58.67 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,331 |
1,320 |
$54.51 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
198 |
193 |
$51.26 |
| 87186 |
|
270 |
252 |
$46.37 |
| 84100 |
|
48 |
37 |
$46.29 |
| 84702 |
|
376 |
276 |
$43.48 |
| 85018 |
|
105 |
79 |
$41.04 |
| 84403 |
|
27 |
26 |
$39.91 |
| 99441 |
|
26 |
25 |
$39.84 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
21 |
12 |
$38.42 |
| 80076 |
|
145 |
136 |
$36.38 |
| 99459 |
|
24 |
12 |
$35.61 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
863 |
712 |
$33.89 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
278 |
236 |
$28.77 |
| 81001 |
|
775 |
710 |
$26.52 |
| 80074 |
|
16 |
15 |
$26.11 |
| 82652 |
|
89 |
86 |
$23.35 |
| 59025 |
Fetal non-stress test |
422 |
200 |
$21.51 |
| 90662 |
|
15 |
15 |
$18.01 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
64 |
39 |
$16.86 |
| 86703 |
|
58 |
57 |
$16.61 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
55 |
54 |
$15.42 |
| 80143 |
|
62 |
56 |
$15.23 |
| 87275 |
|
305 |
293 |
$11.36 |
| 87276 |
|
305 |
293 |
$11.36 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
178 |
172 |
$10.97 |
| 82947 |
|
177 |
168 |
$9.55 |
| 85014 |
|
116 |
92 |
$8.86 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
20 |
13 |
$7.55 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
15 |
12 |
$7.50 |
| 82272 |
|
12 |
12 |
$6.71 |
| 85045 |
|
18 |
17 |
$6.58 |
| 80069 |
|
14 |
12 |
$6.56 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
230 |
172 |
$5.15 |
| A9270 |
Non-covered item or service |
1,001 |
478 |
$4.10 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
18 |
14 |
$3.52 |
| 80179 |
|
43 |
39 |
$3.33 |
| 90674 |
|
14 |
13 |
$1.36 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
152 |
124 |
$0.66 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
14 |
12 |
$0.49 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
21 |
12 |
$0.19 |
| 87660 |
|
261 |
253 |
$0.00 |
| 82565 |
|
27 |
26 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
453 |
437 |
$0.00 |
| 0002A |
|
30 |
30 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
14 |
13 |
$0.00 |
| 73140 |
|
13 |
12 |
$0.00 |
| 80164 |
|
14 |
13 |
$0.00 |
| 83970 |
|
16 |
14 |
$0.00 |
| 82140 |
|
15 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
18 |
12 |
$0.00 |
| 83655 |
|
39 |
39 |
$0.00 |
| 91300 |
|
66 |
66 |
$0.00 |
| 84481 |
|
13 |
13 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
12 |
12 |
$0.00 |
| 86787 |
|
26 |
25 |
$0.00 |
| 86038 |
|
18 |
17 |
$0.00 |
| 84146 |
|
12 |
12 |
$0.00 |
| 87340 |
|
12 |
12 |
$0.00 |
| 87807 |
|
232 |
222 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
74 |
72 |
$0.00 |
| 86592 |
|
41 |
40 |
$0.00 |
| 90686 |
|
35 |
30 |
$0.00 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
68 |
61 |
$0.00 |
| 0001A |
|
33 |
33 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
31 |
26 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
12 |
12 |
$0.00 |
| 86430 |
|
14 |
13 |
$0.00 |
| 84153 |
|
12 |
12 |
$0.00 |
| G8991 |
Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
14 |
12 |
$0.00 |